Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2015
/
Article
/
Tab 1
/
Research Article
MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors
Table 1
MET expression in primary and metastatic renal cell carcinoma (RCC).
Primary RCC
High MET # (%)
Low MET # (%)
Total cases
Metastatic RCC
High MET # (%)
10 (58.8%)
6 (42.9%)
16
Low MET # (%)
7 (41.2%)
8 (57.1%)
15
Total cases
17
14
31